Geneos Wealth Management’s Endava DAVA Stock Holding History

Geneos Wealth Management’s Portfolio DAVA Stock Details DAVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7	Closed	–	–	2628
2022 Q1	$0	Buy	+7	New	+$882	﹤0.01%	2798

Other funds holding DAVA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geneos Wealth Management's DAVA Position: Q2 2022 in Review

Geneos Wealth Management sold out of Endava (DAVA) in Q2 2022, closing a stake of 7 shares.

Geneos Wealth Management first reported a position in DAVA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 185 funds tracked by Wall St. Rank hold DAVA as of Q2 2022.

Geneos Wealth Management reported no remaining Endava position as of Q2 2022 after selling out during the quarter.
Geneos Wealth Management sold 7 Endava shares in Q2 2022.
Geneos Wealth Management first reported a position in Endava in Q1 2022 and held it in 1 quarter.
Geneos Wealth Management's Endava position peaked at $0 in Q1 2022.
185 funds tracked by Wall St. Rank held Endava as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.